Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2020 Feb 26;29(3):643–649. doi: 10.1158/1055-9965.EPI-19-0905

Figure 1. Mouth level nicotine intake.

Figure 1.

Mouth level nicotine intake and 95% confidence intervals calculated using solanesol deposited in cigarette butts collected during Week 6 of clinical trial (n=51–70 participants / group). * denotes significant reduction in mouth level nicotine intake compared to control group (15.8 mg nicotine / g tobacco). HT=high tar